TAG:
specialty lab
More Consolidation: Quest Acquires AML
By Robert Michel | From the Volume IX No. 3 – February 18, 2002 Issue
CEO SUMMARY: In December, American Medical Laboratories, Inc. (AML) was preparing a second attempt to raise capital through an initial public offering (IPO). But a tempting purchase offer by Quest Diagnostics Incorporated led to a decision by AML’s owners to sell the company. This trans…
How Dr. Al Nichols Changed The Lab Testing Marketplace
By Robert Michel | From the Volume IX No. 3 – February 18, 2002 Issue
CEO SUMMARY: At a time when lab testing meant routine assays performed within a few miles of the collection, Albert L. Nichols, M.D. envisioned a centralized national laboratory devoted to performing specialized, highly-complex testing to clinicians everywhere. Not only did his vision bec…
“February 18, 2002 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume IX No. 3 – February 18, 2002 Issue
Lab execs and pathologists should pay close attention to this fact: Internet use by Americans significantly increased again last year. The Commerce Department reported that. as of September, 143 million people in the U.S. were using the Internet. This is 54% of the population and rep…
2001’s Ten Big Stories Presage Future Direction
By Robert Michel | From the Volume VIII No. 17 – December 17, 2001 Issue
CEO SUMMARY: During 2001, few labs found themselves under intense pressure to change or react to dramatic events in the healthcare marketplace. Like 2000, this past year was marked by evolutionary progress, not revolutionary change. However, continuing signs indicate that consumers will p…
ProxyMed & Medscape Select Atlas LabWorks™
By Robert Michel | From the Volume VIII No. 16 – November 26, 2001 Issue
CEO SUMMARY: ProxyMed and MedScape just announced contracts with Atlas Development Corporation. Both companies will integrate Atlas LabWorks™ for electronic test ordering and results reporting into software products they sell to labs and physicians’ offices. Such collaborations again …
Roche, Digene, Centrex, Labtest.com, Specialty Labs, Tripath Imaging
By Robert Michel | From the Volume VIII No. #15 – November 5, 2001 Issue
ROCHE DIAGNOSTICS POSITIONED TO SERVE PUBLIC HEALTH LABS HEIGHTENED CONCERNS over bioterrorist attacks have accelerated plans within the public health lab sector to acquire state-of-the art diagnostic technology in DNA typing and enzyme immunoassay. Roche Diagnostics has in…
Quest Buys New Jersey Lab, Lab Investors Cash In Stock
By Robert Michel | From the Volume VIII No. #15 – November 5, 2001 Issue
THERE’S LOTS OF BUYING and selling taking place among the public laboratory companies. On one side of the spectrum, Quest Diagnostics Incorporated announced the acquisition of Clinical Diagnostic Services, Inc., a private laboratory company based in Englewood, New Jersey. Clinic…
“October 15, 2001 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VIII No. 14 – October 15, 2001 Issue
It’s a sign of the times for managed healthcare. Pacificare Health System, Inc. will offer its first preferred provider organization (PPO) health plan. the PPO is being marketed in California, Oklahoma, and Texas. Enrollment starts this month. Until now Pacificare’s business mode…
Terrorist Attacks Affect Many of Nation’s Labs
By Robert Michel | From the Volume VIII No. 13 – September 24, 2001 Issue
CEO SUMMARY: Following terrorist attacks in New York City and Washington, DC, the total shutdown of commercial air traffic in the United States for 48 hours disrupted the regular shipment of reference and esoteric lab specimens to national laboratories. Swiftly-implemented contingency eff…
Esoterix, Johnson & Johnson, Medtronic, California Hospitals, Myriad Genetics
By Robert Michel | From the Volume VIII No. 8 – June 11, 2001 Issue
ESOTERIX, INC. LAUNCHES TEST REPORTS VIA WEB BROWSER WEB-ACCESSED LAB TEST REPORTING is now available at Esoterix, Inc., based in Austin, Texas. The accomplishment represents a major milestone for the lab company. It now has a common lab test reporting capability that draws…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized